Immunitybio Inc (IBRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2022 | 06-2022 | 03-2022 | 12-2021 | 09-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 104,161 | 61,900 | 36,385 | 181,101 | 64,524 |
| Marketable Securities | 6,896 | 21,038 | 155,947 | 136,015 | 15,848 |
| Other current assets | 1,488 | 1,451 | 3,893 | 1,333 | 1,304 |
| TOTAL | $143,092 | $114,990 | $212,341 | $334,347 | $94,452 |
| Non-Current Assets | |||||
| PPE Net | 130,441 | 119,445 | 105,217 | 82,863 | 69,878 |
| Investments And Advances | 811 | 914 | 865 | 7,597 | 802 |
| Intangibles | 20,471 | 21,738 | 22,349 | 1,420 | 1,432 |
| Other Non-Current Assets | 58,128 | 60,630 | 48,815 | 42,683 | 47,857 |
| TOTAL | $209,851 | $202,727 | $177,246 | $134,563 | $119,969 |
| Total Assets | $352,943 | $317,717 | $389,587 | $468,910 | $214,421 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 23,255 | 22,211 | 15,427 | 15,361 | 23,817 |
| Accrued Expenses | 46,220 | 52,351 | 62,468 | 51,387 | 38,519 |
| TOTAL | $70,840 | $376,050 | $381,014 | $368,995 | $65,408 |
| Non-Current Liabilities | |||||
| Long Term Debt | 373,293 | 312,541 | 309,428 | 306,349 | 303,240 |
| Other Non-Current Liabilities | 338,114 | 51,185 | 36,711 | 37,773 | 36,347 |
| TOTAL | $711,184 | $363,641 | $346,129 | $343,828 | $338,957 |
| Total Liabilities | $782,024 | $739,691 | $727,143 | $712,823 | $404,365 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 400,304 | 400,304 | 397,957 | 397,911 | 397,595 |
| Common Shares | 40 | 40 | 40 | 40 | 39 |
| Retained earnings | -2,270,273 | -2,159,335 | -2,064,747 | -1,961,921 | -1,870,662 |
| Other shareholders' equity | -2,572 | -2,269 | -2,279 | -1,736 | -1,393 |
| TOTAL | $-429,081 | $-421,974 | $-337,556 | $-243,913 | $-189,944 |
| Total Liabilities And Equity | $352,943 | $317,717 | $389,587 | $468,910 | $214,421 |